FDA Center for Drug Evaluation & Research Issues Warning Letter to Spa De Soleil
July 15, 2026
July 15, 2026
WASHINGTON, July 15 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Spa De Soleil Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Ms. Rena Revivo, Owner, Spa De Soleil, Inc., 10443 Arminta Street, Sun Valley, CA 91352-4109, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-100
* * *
Recipient: Ms. Rena Revivo, Owner, Spa De Soleil, Inc., 10443 Arminta Street, Sun Valley, CA 91352-4109, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-100